These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37558742)
1. Abrogation of greater graft failure risk of female-to-male liver transplantation with donors older than 40 years or graft macrosteatosis greater than 5. Han S; Kwon JH; Lee KW; Lee S; Choi GS; Kim JM; Ko JS; Gwak MS; Kim GS; Ha SY; Joh JW Sci Rep; 2023 Aug; 13(1):12914. PubMed ID: 37558742 [TBL] [Abstract][Full Text] [Related]
2. Sequential Protocol Biopsies Post-Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat? Croome KP; Livingston D; Croome S; Keaveny AP; Taner CB; Nakhleh R Liver Transpl; 2021 Feb; 27(2):248-256. PubMed ID: 32779325 [TBL] [Abstract][Full Text] [Related]
3. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis. Altshuler PJ; Dang H; Frank AM; Shah AP; Glorioso J; Zhan T; Rios Diaz A; Shaheen O; Ramirez CB; Maley WR; Bodzin AS Liver Transpl; 2022 Apr; 28(4):623-635. PubMed ID: 34564931 [TBL] [Abstract][Full Text] [Related]
4. Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity. Lee KW; Han S; Lee S; Cha HH; Ahn S; Ahn HS; Ko JS; Gwak MS; Kim GS; Joh JW; Lee SK; Choi GS Transplantation; 2018 Jul; 102(7):1115-1123. PubMed ID: 29443826 [TBL] [Abstract][Full Text] [Related]
5. Hepatic macrosteatosis in the US pediatric deceased liver donor population. Purvis JW; Orandi BJ; Dhall D; McLeod C; Gutierrez Sanchez LH; Gray M; Frey K; Sheikh SS; Cannon RM; Terrault NA; Lewis CE; Locke JE Pediatr Transplant; 2022 Feb; 26(1):e14155. PubMed ID: 34590386 [TBL] [Abstract][Full Text] [Related]
6. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes. Zhang WJ; Xia WL; Pan HY; Zheng SS Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):487-492. PubMed ID: 27733317 [TBL] [Abstract][Full Text] [Related]
7. Outcome for Pediatric Recipients of Macrosteatotic Liver Grafts From Living Donors. Irie R; Nakazawa A; Sakamoto S; Takeda M; Yanagi Y; Shimizu S; Uchida H; Fukuda A; Kasahara M Liver Transpl; 2020 Jul; 26(7):899-905. PubMed ID: 32314485 [TBL] [Abstract][Full Text] [Related]
8. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923 [TBL] [Abstract][Full Text] [Related]
9. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation. Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852 [TBL] [Abstract][Full Text] [Related]
10. Excellent outcome following transplantation of a domino donor liver with high-grade macrosteatosis. Azabdaftari G; Pomfret EA; Simpson MA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD; Khettry U Pathol Res Pract; 2004; 200(7-8):581-7; discussion 589-90. PubMed ID: 15462507 [TBL] [Abstract][Full Text] [Related]
11. Macrosteatotic and nonmacrosteatotic grafts respond differently to intermittent hepatic inflow occlusion: Comparison of recipient survival. Han S; Choi GS; Kim JM; Kwon JH; Park HW; Kim G; Kwon CH; Gwak MS; Ko JS; Joh JW Liver Transpl; 2015 May; 21(5):644-51. PubMed ID: 25690881 [TBL] [Abstract][Full Text] [Related]
12. Quantifying the Effect of Transplanting Older Donor Livers Into Younger Recipients: The Need for Donor-recipient Age Matching. Bittermann T; Goldberg DS Transplantation; 2018 Dec; 102(12):2033-2037. PubMed ID: 29965955 [TBL] [Abstract][Full Text] [Related]
13. The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation. Lozanovski VJ; Khajeh E; Fonouni H; Pfeiffenberger J; von Haken R; Brenner T; Mieth M; Schirmacher P; Michalski CW; Weiss KH; Büchler MW; Mehrabi A Langenbecks Arch Surg; 2018 Sep; 403(6):719-731. PubMed ID: 30112639 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R; Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192 [TBL] [Abstract][Full Text] [Related]
15. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival. Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675 [TBL] [Abstract][Full Text] [Related]
16. Sex Difference in the Tolerance of Hepatic Ischemia-reperfusion Injury and Hepatic Estrogen Receptor Expression According to Age and Macrosteatosis in Healthy Living Liver Donors. Han S; Cho J; Wi W; Won Lee K; Hwa Cha H; Lee S; Hyun Ahn J; Kim S; Sung Choi G; Man Kim J; Ha SY; Soo Kim G; Joh JW Transplantation; 2022 Feb; 106(2):337-347. PubMed ID: 33982906 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients. Croome KP; Lee DD; Burns JM; Saucedo-Crespo H; Perry DK; Nguyen JH; Taner CB; Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067 [TBL] [Abstract][Full Text] [Related]
18. Single-Center Experience Using Marginal Liver Grafts in Korea. Park PJ; Yu YD; Yoon YI; Kim SR; Kim DS Transplant Proc; 2018 May; 50(4):1147-1152. PubMed ID: 29731083 [TBL] [Abstract][Full Text] [Related]
19. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality. Alvikas J; Deeb AP; Jorgensen DR; Minervini MI; Demetris AJ; Lemon K; Chen X; Labiner H; Malik S; Hughes C; Humar A; Tevar A Transplant Proc; 2021 Jun; 53(5):1682-1689. PubMed ID: 33931249 [TBL] [Abstract][Full Text] [Related]